fda bpc-157 not approved for human use warning letter "This is so scary me because anytime you're injecting a medicine to the body that is well studied in humans... that's incredibly frightening, especially since they're not approved.", "The Heal or Harm: Body Protective

Typical injectable GHK-Cu dose ranges Standard starting dose: 1 mg per day subcutaneous Conservative / beginner dose: 0.5 mg per day Intensive / wound-healing dose: 23 mg per day Upper research range: 4 mg per day (rarely exceeded) Frequency: once daily, or split into morning + evening microdoses for steadier levels Route: subcutaneous (SC) injection - typically abdomen , thigh or flank

This deficiency can be caused by poor dietary consumption, a breakdown in the digestive process, or from taking certain medications that make it difficult to absorb B12 (such as antacids)

[DOI] [PubMed] [Google Scholar] 29.World Health Organization

Therefore, we performed pharmacokinetic studies of BPC157 in beagle dogs following single IV administration at a dose of 6 g/kg, single IM administration at doses of 6, 30, or 150 g/kg, and repeated IM administration at a dose of 30 g/kg for seven consecutive days

Batch CoAs are published so the documentation can be checked against the vial before any work begins

Whether you are supporting immunity, improving energy, or combining therapies like NAD+ and peptides for long-term health, we are here to help you feel better today while building a stronger foundation for the future